Myriad Genetics Inc. | Mutual Funds
Mutual Funds that own Myriad Genetics Inc.
iShares Core S&P Small Cap ETF
3,863,131
5.45%
1,095
0.4%
09/06/2018
Vanguard Small Cap Index Fund
1,758,751
2.48%
22,184
0.09%
07/31/2018
Vanguard Total Stock Market Index Fund
1,757,328
2.48%
2,162
0.01%
07/31/2018
iShares Russell 2000 ETF
1,389,457
1.96%
-741
0.14%
09/06/2018
Baillie Gifford UK & Balanced Fund - Global Alpha Growth
1,316,885
1.86%
1,029,471
1%
04/30/2018
Government Pension Fund - Global (The)
1,310,443
1.85%
451,471
0.01%
12/31/2017
SPDR S&P Biotech ETF
1,287,836
1.82%
3,312
1.1%
09/06/2018
iShares S&P Small Cap 600 Growth ETF
1,198,801
1.69%
1,720
0.82%
09/06/2018
Vanguard Small Cap Value Index Fund
1,104,147
1.56%
9,515
0.17%
07/31/2018
DFA US Small Cap Value Portfolio
1,018,417
1.44%
-242,633
0.25%
04/30/2018
| Address |
320 Wakara Way
Salt Lake City Utah 84108
United States
|
|
Employees
|
- |
| Website |
http://www.myriad.com |
| Updated |
07/08/2019 |
| Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through Diagnostics and Other segments. The Diagnostics segment engages in the provision of testing and collaborative development of testing that is designed to asses a risk of developing a disease later in life of an individual. |
